相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Co-Inhibition of BCL-W and BCL2 Restores Antiestrogen Sensitivity through BECN1 and Promotes an Autophagy-Associated Necrosis
Anatasha C. Crawford et al.
PLOS ONE (2010)
Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells
Robert Clarke et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Daniel J. Klionsky et al.
AUTOPHAGY (2008)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the development of antiestrogen resistance
Julia S. Samaddar et al.
MOLECULAR CANCER THERAPEUTICS (2008)
P53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation
Keiko Kawauchi et al.
NATURE CELL BIOLOGY (2008)
Id-1 regulates Bcl-2 and Bax expression through p53 and NF-κB in MCF-7 breast cancer cells
Hwan Kim et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice
Masaaki Komatsu et al.
CELL (2007)
Enhanced NFκB and AP-I transcriptional activity associated with antiestrogen resistant breast cancer
Yamei Zhou et al.
BMC CANCER (2007)
Endocrine therapy resistance can be associated with high estrogen receptor α (ERα) expression and reduced ERα phosphorylation in breast cancer models
Barbara Kuske et al.
ENDOCRINE-RELATED CANCER (2006)
Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion
Lingegowda S. Mangala et al.
MOLECULAR CANCER (2005)
Pro-apoptotic Bid induces membrane perturbation by inserting selected lysolipids into the bilayer
A Goonesinghe et al.
BIOCHEMICAL JOURNAL (2005)
Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase
H Nakshatri et al.
ONCOGENE (2004)
Nuclear factor-KB: a friend or a foe in cancer?
S Shishodia et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer
EA Curry et al.
INVESTIGATIONAL NEW DRUGS (2004)
Nuclear factor (NF)-κB proteins:: therapeutic targets
IM Verma
ANNALS OF THE RHEUMATIC DISEASES (2004)
Interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (Faslodex, Fulvestrant)
KB Bouker et al.
CANCER RESEARCH (2004)
Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling
R Clarke et al.
ONCOGENE (2003)
Estrogen withdrawal-induced NF-κB activity and Bcl-3 expression in breast cancer cells:: Roles in growth and hormone independence
MAC Pratt et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Oxidative stress-mediated apoptosis - The anticancer effect of the sesquiterpene lactone parthenolide
J Wen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
AS Baldwin
JOURNAL OF CLINICAL INVESTIGATION (2001)
Differential sensitivity of MCF-7 and LCC2 cells, to multiple growth inhibitory agents: possible relation to high bcl-2/bax ratio?
G Lilling et al.
CANCER LETTERS (2000)
Mitochondria as the central control point of apoptosis
S Desagher et al.
TRENDS IN CELL BIOLOGY (2000)
Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolide
NM Patel et al.
ONCOGENE (2000)
Activation of NF-κB/Rel occurs early during neoplastic transformation of mammary cells
DW Kim et al.
CARCINOGENESIS (2000)
Selective activation of NF-κB subunits in human breast cancer:: potential roles for NF-κB2/p52 and for Bcl-3
PC Cogswell et al.
ONCOGENE (2000)
Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane
R Eskes et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
